Visualization of Hepatic Uptake Transporter Function in Healthy Subjects by Using Gadoxetic Acid–enhanced MR Imaging
Authors:
- Jia JiaJJJia Jia
- Markus KeiserMKMarkus Keiser
- Stefan OswaldSOStefan Oswald
- Christiane ModessCMChristiane Modess
- Stefan NagelSNStefan Nagel
- Werner WeitschiesWerner Weitschies
- Norbert HostenNHNorbert Hosten
- Werner SiegmundWSWerner Siegmund
- Jens-Peter KühnJKJens-Peter Kühn
- 1 September 2012
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 264 (3) , 741-750
Abstract
The liver-specific human organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 are uptake carriers for gadoxetic acid, the activity of which may be used to predict the signal intensity in gadoxetic acid-enhanced liver MR imaging. PurposeTo determine if genetic polymorphisms of liver-specific human organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 influence cellular uptake of gadoxetic acid in vitro and if functionally relevant polymorphisms are confounders for liver enhancement by gadoxetic acid in healthy subjects.Materials and MethodsThis study received ethics approval, and all subjects provided written informed consent. Cellular uptake of gadoxetic acid by OATP1B1 and OATP1B3 and their frequent genetic variants was measured by using stable transfected embryonic kidney HEK293 cells. Liver signal intensity at gadoxetic acid–enhanced MR imaging and pharmacokinetics of gadoxetic acid were evaluated in 36 healthy carriers of SLCO1B1/1B3 wild-type alleles (n = 10), SLCO1B1*1b/*1b (n = 8), SLCO1B1*15/*15 (n = 7), SLCO1B1*5/*15 (n = 1), SLCO1B1*1a/*5 (n = 6), and SLCO1B3*4/*4 (n = 4) by using T1-weighted MR imaging and liquid chromatography tandem mass spectrometry.ResultsTransport activity for gadoxetic acid was increased ...Keywords
This publication has 37 references indexed in Scilit:
- Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificityPharmacogenetics and Genomics, 2011
- Relationship Between Liver Function and Liver Signal Intensity in Hepatobiliary Phase of Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance ImagingJournal of Computer Assisted Tomography, 2010
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Liver parenchymal enhancement of hepatocyte‐phase images in Gd‐EOB‐DTPA‐enhanced MR imaging: Which biological markers of the liver function affect the enhancement?Journal of Magnetic Resonance Imaging, 2009
- Impact of OATP transporters on pharmacokineticsBritish Journal of Pharmacology, 2009
- Impact of regulatory polymorphisms in organic anion transporter genes in the human liverPharmacogenetics and Genomics, 2009
- Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinomaJournal of Gastroenterology, 2009
- Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8)Pharmacogenetics, 2004
- Gadolinium-Ethoxybenzyl-Diethylenetriamine-Pentaacetic Acid Interaction With Clinical Drugs in RatsInvestigative Radiology, 2002
- Comparison of Gd‐EOB‐DTPA and Gd‐DTPA for contrast‐enhanced MR imaging of liver tumorsJournal of Magnetic Resonance Imaging, 1993